LanZhou Foci PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
LanZhou Foci PharmaceuticalLtd has a total shareholder equity of CN¥1.8B and total debt of CN¥37.9M, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are CN¥2.5B and CN¥740.4M respectively. LanZhou Foci PharmaceuticalLtd's EBIT is CN¥54.3M making its interest coverage ratio -18.9. It has cash and short-term investments of CN¥365.3M.
Key information
2.1%
Debt to equity ratio
CN¥37.93m
Debt
Interest coverage ratio | -18.9x |
Cash | CN¥365.34m |
Equity | CN¥1.79b |
Total liabilities | CN¥740.43m |
Total assets | CN¥2.53b |
Recent financial health updates
No updates
Recent updates
LanZhou Foci PharmaceuticalLtd's (SZSE:002644) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 17LanZhou Foci Pharmaceutical Co.,Ltd.'s (SZSE:002644) 26% Price Boost Is Out Of Tune With Earnings
Mar 13LanZhou Foci Pharmaceutical Co.,Ltd.'s (SZSE:002644) 26% Price Boost Is Out Of Tune With Earnings
Mar 13Financial Position Analysis
Short Term Liabilities: 002644's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥462.4M).
Long Term Liabilities: 002644's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥278.0M).
Debt to Equity History and Analysis
Debt Level: 002644 has more cash than its total debt.
Reducing Debt: 002644's debt to equity ratio has increased from 0% to 2.1% over the past 5 years.
Debt Coverage: 002644's debt is well covered by operating cash flow (141.3%).
Interest Coverage: 002644 earns more interest than it pays, so coverage of interest payments is not a concern.